These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1444557)

  • 21. Effect of dexamethasone therapy on serum vitamin E concentrations in premature infants with bronchopulmonary dysplasia.
    Amin SB; Laroia N; Sinkin RA; Kendig JW
    J Perinatol; 2003 Oct; 23(7):552-5. PubMed ID: 14566351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia.
    Ng PC; Wong GW; Lam CW; Lee CH; Fok TF; Wong MY; Wong W; Chan DC
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2429-32. PubMed ID: 9253312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin A and bronchopulmonary dysplasia: research, issues, and clinical practice.
    Mentro AM
    Neonatal Netw; 2004; 23(4):19-23. PubMed ID: 15317375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of intravenous ranitidine on the intragastric pH of preterm infants receiving dexamethasone.
    Kelly EJ; Chatfield SL; Brownlee KG; Ng PC; Newell SJ; Dear PR; Primrose JN
    Arch Dis Child; 1993 Jul; 69(1 Spec No):37-9. PubMed ID: 8346951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Supplementary parenteral nutrition in premature infants. Adaptation to amino acid intake].
    Salle B; Rigo J; Senterre J; Putet G; Claris-Meunier G
    Arch Fr Pediatr; 1987 Jan; 44(1):5-8. PubMed ID: 3105512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of postnatal steroid administration on serum vitamin A concentrations in newborn infants with respiratory compromise.
    Georgieff MK; Mammel MC; Mills MM; Gunter EW; Johnson DE; Thompson TR
    J Pediatr; 1989 Feb; 114(2):301-4. PubMed ID: 2915291
    [No Abstract]   [Full Text] [Related]  

  • 27. Response to dexamethasone in ventilated preterm infants: effect of radiographic subtype of chronic lung disease.
    Kothadia JM; O'Shea TM; Auringer ST; Dillard RG
    Am J Perinatol; 1996 Aug; 13(6):377-81. PubMed ID: 8865986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dexamethasone in the treatment of bronchopulmonary dysplasia].
    Schrod L; Frauendienst-Egger G; Forgber I; von Stockhausen HB
    Pneumologie; 1991 Nov; 45(11):892-6. PubMed ID: 1762998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone for neonatal chronic lung disease.
    Lancet; 1991 Oct; 338(8773):982-3. PubMed ID: 1681347
    [No Abstract]   [Full Text] [Related]  

  • 30. Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo-controlled trials.
    Onland W; Offringa M; De Jaegere AP; van Kaam AH
    Pediatrics; 2009 Jan; 123(1):367-77. PubMed ID: 19117904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catabolic effect in premature infants with early dexamethasone treatment.
    Tsai FJ; Tsai CH; Wu SF; Liu YH; Yeh TF
    Acta Paediatr; 1996 Dec; 85(12):1487-90. PubMed ID: 9001663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-mobility group box-1 protein in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia and steroid therapy.
    Aghai ZH; Saslow JG; Meniru C; Porter C; Eydelman R; Bhat V; Stahl G; Sannoh S; Pyon K; Hewitt C; Bhandari V
    J Perinatol; 2010 Sep; 30(9):610-5. PubMed ID: 20182437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial parenteral nutrition in preterm and newborn infants during the first three days of life.
    Henze G; Lautner H; Neubrand W; Werner E
    JPEN J Parenter Enteral Nutr; 1979; 3(4):231-4. PubMed ID: 113590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia.
    Brand PL; van Lingen RA; Brus F; Talsma MD; Elzenga NJ
    Acta Paediatr; 1993; 82(6-7):614-7. PubMed ID: 8339005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysosomal enzymes in preterm infants with bronchopulmonary dysplasia: a potential diagnostic marker.
    Goi G; Bairati C; Massaccesi L; Lombardo A; Bonafè L; Zanardo V; Burlina A
    Clin Chim Acta; 1998 Nov; 278(1):23-34. PubMed ID: 9877121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of parenteral glutamine supplementation on plasma amino acid concentrations in extremely low-birth-weight infants.
    Poindexter BB; Ehrenkranz RA; Stoll BJ; Koch MA; Wright LL; Oh W; Papile LA; Bauer CR; Carlo WA; Donovan EF; Fanaroff AA; Korones SB; Laptook AR; Shankaran S; Stevenson DK; Tyson JE; Lemons JA;
    Am J Clin Nutr; 2003 Mar; 77(3):737-43. PubMed ID: 12600870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma amino acids in preterm infants fed on human milk or formula.
    Bell AH; Halliday HL; McClure G; McC Reid M
    Arch Dis Child; 1988 Aug; 63(8):996-7. PubMed ID: 3415342
    [No Abstract]   [Full Text] [Related]  

  • 38. Postnatal glucocorticoids in very preterm infants: "the good, the bad, and the ugly"?
    Thébaud B; Lacaze-Masmonteil T; Watterberg K
    Pediatrics; 2001 Feb; 107(2):413-5. PubMed ID: 11158479
    [No Abstract]   [Full Text] [Related]  

  • 39. Dexamethasone therapy in preterm infants developing bronchopulmonary dysplasia: effect on pulmonary surfactant disaturated-phosphatidylcholine kinetics.
    Cogo PE; Simonato M; Mariatoffolo G; Stefanutti G; Chierici M; Cobelli C; Ori C; Carnielli VP
    Pediatr Res; 2008 Apr; 63(4):433-7. PubMed ID: 18356753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
    Watterberg KL;
    Pediatrics; 2010 Oct; 126(4):800-8. PubMed ID: 20819899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.